Novavax starts COVID-19 vaccine trial for children aged six months to 11 years

Retrieved on: 2022-08-04 21:03:45

Tags for this article:

Click the tags to see associated articles and topics

Novavax starts COVID-19 vaccine trial for children aged six months to 11 years. View article details on hiswai:

Excerpt

The trial will evaluate the safety, effectiveness (immunogenicity), and efficacy of two doses of the Novavax COVID-19 vaccine (NVX-CoV2373) in ...

Article found on: www.labiotech.eu